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Abstract The regenerating islet-derived (REG) gene family
encodes a group of proteins highly expressed in several
human pathologies, many of which are associated with
epithelial inflammation. All human family members, name-
ly REG1A, REG1B, REG3A and REG4, are closely related
in genomic sequence and all are part of the c-type lectin
superfamily. REGs are highly expressed during inflamma-
tory bowel disease (IBD)-related colonic inflammation and
the in vivo expression pattern of REG1A and REG4 has
been localised by using immunohistochemistry. However,
the function of the encoded proteins is largely unknown and
the cellular localisation of REG expression during colonic
inflammation has not been described. Therefore, we have
used in situ hybridisation to demonstrate the cellular
localisation of REG expression in healthy and diseased
colonic mucosa. Samples drawn from an IBD cohort includ-
ing both inflamed and un-inflamed colonic mucosa are
described, as are samples from non-IBD inflammation and
healthy controls. Immunohistochemistry against known
cell-type markers on serial sections has localised the expres-
sion of REGs to metaplastic Paneth cells (REG1A, REG1B
and REG3A) and enteroendocrine cells (REG4), with a
marked expansion of expression during inflammation. The
group of REGs can, based on gene expression patterns, be
divided into at least two groups; REG1A, REG1B and
REG3A with their expression focused in the crypt base
spreading from Paneth cells and REG4 being more highly
expressed towards the luminal face. This exploration of
expression pattern forms provides the background for fur-
ther exploration of REG function in the intestine.
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Introduction
Since the discovery of the regenerating islet-derived (REG)
gene family in connection with islet regeneration after ex-
perimental injury to rat pancreas, several studies have ex-
plored the possible functions and expression patterns of the
various genes in the family. In the beginning, these studies
focused mainly on the role of REG in ailments affecting the
pancreas, such as diabetes, acute pancreatitis and pancreatic
cancer. Today, we know that REG family proteins are highly
expressed in the epithelial lining of many organs in connec-
tion with tissue injury and inflammation.
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In humans, the REG gene family currently consists in
four well-established members: REG1A, REG1B, REG3A
and REG4. All are found encoded in tandem on chromo-
some 2p12, except for REG4, which is found on 1p12. The
intron-exon arrangement of all REGs are similar, again
except for REG4, which has considerably longer intronic
sequences (Zelensky and Gready 2005). The protein se-
quence suggests similarities to the C-dependent lectins,
although the carbohydrate-binding motif of the REGs does
not display the calcium-binding site common for other
members of the superfamily. Our current knowledge of
human REG protein function and its expression pattern have
recently been reviewed by Parikh et al. (2012).
The suggested functions of the various REGs are many
and surprisingly diverse, given the great similarity in the
sequence of the members. Of the human REGs, REG1A,
REG3A and REG4 are the best studied. All REGs are
expressed in the pancreas and small intestine, whereas only
REG4 is constitutively expressed in colon epithelia (Zhang et
al. 2003). During epithelial disease, in either pancreatitis or
inflammation of the bowel, the expression of REGs in-
creases. Both high REG4 and REG1A expression has been
linked to poor prognosis in colorectal cancer (Astrosini et al.
2008; Oue et al. 2007) and both have been shown to have
either a trophic or an anti-apoptotic effect. The effect of
REG4 has been further investigated by using cancer cell
lines and the results suggest that REG4 can stimulate both
cell migration and proliferation (Guo et al. 2010; Rafa et al.
2010). Sekikawa et al. (2010) have demonstrated that the
increase in REG1A expression seen in inflamed colonic
mucosa correlates with IL22 expression and is stimulated
in a STAT3-dependent manner. An antimicrobial effect has
been demonstrated for murine Reg3g and human REG3A
and is possibly specific for membrane-bound peptidoglycans
of Gram-positive bacteria (Cash et al. 2006).
REG1A, REG1B, REG3A and REG4 all show increased
expression during inflammatory bowel disease (IBD)-relat-
ed inflammation of the colon (Dieckgraefe et al. 2002;
Granlund et al. 2011; Lawrance et al. 2001). IBD is a group
of chronic diseases affecting as many as 2.2 million Euro-
peans and 1.4 million US citizens (Loftus 2004). The two
main IBD subtypes, ulcerative colitis (UC) and Crohn’s
disease (CD), are clinically distinct. They do, however,
share many features such as chronic mucosal inflammation
and epithelial injury. Despite the initial discovery of the high
expression of REGs during IBD inflammation, few studies
have investigated their expression pattern in the inflamed
bowel mucosa. Dieckgraefe et al. (2002) have described
REG1A in IBD by using immunohistochemistry (IHC);
the protein is expressed by metaplastic Paneth cells of the
inflamed colonic mucosa. In a comprehensive study by Oue
et al. (2005), the expression patterns of REGIV (REG4) in
many neoplastic and non-neoplastic tissues have been
determined, with REG4 protein expression in normal colon-
ic tissue being shown to be limited to enteroendocrine cells.
In a previous study, we have found REG mRNAs to be
strongly up-regulated during inflammation of the colon. We
have further examined, using IHC, the expression pattern of
REG1A and REG4 in both in the un-inflamed and inflamed
colonic mucosa from UC and CD patients, in normal colon-
ic mucosa and in inflamed mucosa from patients with non-
IBD antibiotic-induced pseudomembranous colitis (PC;
Granlund et al. 2011). Whereas no REG1A expression is
seen in normal mucosa, the Paneth cells found both in un-
inflamed and inflamed IBD tissue and in inflamed tissue
from patients with PC express REG1A protein. REG4 has
been seen in serotonin-positive cells in all colonic samples.
During inflammation, the expression of both REG1A
and REG4 shifts to include all other epithelial cells of
the colonic crypts, with expression for REG4 increasing
towards the lumen and for REG1A increasing towards
the crypt base.
Present knowledge of the mRNA expression patterns of
the various REGs in human colonic mucosa is extremely
limited, with only a few studies demonstrating the expres-
sion of REG1A and REG4 in colorectal cancer and
pseudomyxoma peritonei of the appendix (Astrosini et al.
2008; Heiskala et al. 2006). In the present study, we have
utilised an in situ hybridisation (ISH) method involving
branched-chain DNA technology, enabling us, for the first
time, to localise all human REGs in normal and inflamed
colon. Protein expression has been studied with regard to the
REGs for which antibodies are available. The expression
pattern has been further investigated by identifying cell
types expressing the various REGs by using IHC against
appropriate cell-type markers in serial sections. The cur-
rent study represents a comprehensive evaluation of REG
expression pattern in the healthy and inflamed colon and
will provide the necessary background information in




Sample material was drawn from a research biobank of IBD
samples at St. Olav’s University Hospital, except for sam-
ples of PC, which were taken from the clinical files at the
Department of Pathology, St. Olav’s University Hospital.
Samples for IHC, ISH and microarray analysis were pre-
pared as described previously (Granlund et al. 2011). In
total, six groups of samples were defined: normal mucosa
from healthy individuals (N), un-inflamed mucosa from the
hepatic flexure (HF) in UC patients (UCU), un-inflamed
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mucosa from HF in CD patients (CDU), inflamed colonic
mucosa from UC patients (UC), inflamed colonic mucosa
from CD patients (CD) and inflamed mucosa from PC
patients (PC). For the IBD samples and normal controls,
the procedure was as follows (in brief). Four samples from
the same area were collected from each patient by pinch
biopsy during colonoscopy. Three were snap-frozen and fur-
ther stored in liquid nitrogen, with one biopsy being fixed in
formalin and subsequently embedded in paraffin. All un-
inflamed biopsies from IBD patients and normal samples from
healthy controls were taken from the hepatic flexure. Diseased
samples were taken from areas in which the mucosa was
macroscopically maximally inflamed. Hematoxylin-eosin
(H-E)-stained sections from all samples were evaluated by
an expert pathologist for verification of the diagnosis. Samples
for which microscopic evaluation diverged from the initial
endoscopic diagnosis were removed from the sample pool.
Informed written consent was obtained from all study partic-
ipants. The study was approved by The Regional Medical
Research Ethics Committee (no. 5.2007.910) and was regis-
tered in the Clinical Trials Protocol Registration System (iden-
tifier NCT00516776).
Microarray gene expression analysis
Samples were prepared and data were analysed as described
previously (Granlund et al. 2011). In brief, all RNA samples
were controlled for RNA integrity and purity. Samples not
fulfilling the quality requirements were removed prior to
microarray analysis. In addition to the technology-specific
quality controls supplied by Illumina, two samples were
used as technical controls. One of these samples was
hybridised to each 12-plex chip in order to detect any
deviation in results. All data from the microarray analysis
were analysed by using Bioconductor in the R statistical
computing environment (Gentleman et al. 2004). In short,
data were log-transformed and quantile-normalised and dif-
ferential expression was identified by using limma linear
regression (Smyth 2005). All P-values were corrected for
multiple comparisons by using the Benjamini-Hochberg
correction. The significance level was set to a corrected
P-value of <0.05. All data from this analysis are available
in ArrayExpress E-MTAB-184. A verification of the
observed regulation of REG family genes by quantitative
reverse transcription plus the polymerase chain reaction is
given in a previous publication by Granlund et al. (2011).
Histological and immunohistological examination
Paraffin-embedded samples were cut into sections of 4 μm
in thickness and mounted on glass slides. Three PC samples
and five samples from each IBD sample group and normal
controls were randomly selected. One section from each
sample was stained with H-E for the evaluation of inflam-
matory status by an experienced pathologist. From each
group, two samples displaying good crypt morphology were
selected based on the evaluation of H-E-stained sections.
These samples then formed the basis for the further evalua-
tion of REG expression. This process was repeated twice,
giving a total number of evaluated colonic samples of 12.
The images shown in Results are all based on the six samples
given in Table 1. For IHC and ISH, sequential pairs of
sections were mounted with adjoining sides facing up in
order to optimise serial section staining. Antibodies for
REG1A (cat. no. RD181078100, BioVendor, Midrice, Czech
Republic; dilution 1:500), REG4 (REGIV, cat. no. AF1379,
R&D Systems, Minneapolis, Minn., USA; dilution 1:400),
REG3A (cat. no. AB134209, Abcam, Cambridge, UK; dilu-
tion 1:100), Defensin alpha 6 (DEFA6, cat. no. HPA019462,
Sigma, St. Louis, Mo., USA; dilution 1:1000) and serotonin
(5HT, cat. no. AB16007, Abcam; dilution 1:200) were all
commercially available. REG1A, REG3A, DEFA6 and se-
rotonin were detected by using the Dako EnVision peroxi-
dase kit (Dako, Glostrup, Denmark), whereas REGIV
(REG4) was detected by using the Vectastain ABC kit
(Vector Laboratories, Burlingame, Calif., USA). Dako
DAB+ (diaminobenzidine) was used as the chromogene for
all IHC, with all sections being counterstained with hema-
toxylin. Samples were de-paraffinised in Neo-Clear (Merck
Millipore, Darmstadt, Germany) and antigen retrieval was
performed by boiling sections in either sodium citrate (pH
6.0) or TRIS-EDTA (pH9.0) buffer for 15 min. For ISH of
REG1A, REG1B, REG3A, REG4 and Chromogranin A
(CgA), the RNAscope 2.0 single-plex hybridisation system
(Advanced Cell Diagnostics, Hayward, Calif., USA) was
used according to the manufacturer’s recommendations. This
Table 1 Patient characteristics
(N normal, UC ulcerative colitis,
CD Crohn’s disease, PC
pseudomembranous colitis)
Diagnosis (sample ID) Inflammatory status Sample Area Sex Age (years)
N (205 F) Un-inflamed Hepatic flexure Male 51
UC (147 F) Un-inflamed Hepatic flexure Male 37
CD (212 F) Un-inflamed Hepatic flexure Male 42
UC (122 S) Inflamed Sigmoid Female 47
CD (212 S) Inflamed Sigmoid Male 42
PC (23590) Inflamed Splenic flexure Male 71
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method utilises branched-chain DNA technology to ensure
good specificity and sensitivity (Player et al. 2001). In
brief, tissue sections were heated (1 h, 60 °C) prior to de-
paraffinisation and rehydration, followed by a protease
treatment (30 min, 42 °C in a humidifying chamber). Each
slide was hybridised with target probe for 1 h at 40 °C,
followed by a series of specific signal amplification steps
as described in the manufacturer’s protocol and was
stained for 10 min by using DAB provided by the man-
ufacturer. All sections were counterstained with hematox-
ylin. Initial hybridisation for each probe was performed
including positive and negative controls in order to ensure
proper target probe specificity. Control probes were pro-
vided by Advanced Cell Diagnostics. Positive controls
targeted ubiquitin C, whereas negative control probes
targeted bacterial dapB. All samples used in the final
analysis performed as expected when hybridised with
positive and negative control probes. Examples of positive
and negative controls are given in Fig. S1.
All images were acquired by using NIS-Elements BR ver.
3.00 (Nikon Instruments, Melville, N.Y., USA). The white
balance was automatically adjusted for each picture by
means of the routines provided. Images were saved as
TIFF-files. Subsequent image orientation and cropping
was used to ease interpretation of serial sections.
Results
Samples
After evaluation of morphology, two samples from each
group were selected for initial ISH. Fixation time for the
samples varied and was unknown. As fixation time influ-
ences ISH strongly, this initial analysis was performed to
ensure compatibility of the sample with the ISH protocol.
The samples showing consistent results were used in the
subsequent analysis. Sample information is given in Table 1.
All samples used in the final analysis were tested with
positive and negative control probes supplied by the
manufacturer of the ISH kit. Quality controls showed min-
imal un-specific binding of the negative control probe and
good hybridisation of the positive control probe. The anal-
ysis was repeated twice with separate sets of samples in
order to confirm findings.
Microarray analysis
Results from the full microarray gene expression analysis
have been described in previous publications (Granlund et
al. 2011). All REG mRNAs were potently regulated in
inflamed mucosa from UC and CD and were among the
top eight differentially expressed genes for the contrast
UC vs. N. The analysis did not show significant regula-
tion of REG genes in un-inflamed samples but a subset
of samples showed an expression level similar to that
seen in inflamed samples.
For the present study, the REG expression levels for
the randomly selected samples used in IHC/ISH analysis
were extracted from the full set of microarray results.
The LOG2 expression levels of the present samples are
given in Table 2. The normal control had REG levels
close to background, except for REG4, which displayed a
basal expression slightly over background. The CDU
sample exhibited a slight increase in the expression of
all REGs, whereas the UCU sample had expression
levels similar to inflamed samples thereby reflecting the
dichotomous distribution of REG expression in un-
inflamed IBD samples.
ISH and IHC analyses
Normal samples showed no ISH staining for REG1A, REG1B
and REG3. For REG4, scattered cells showed positivity and
were identified as serotonin-positive enteroendocrine cells.
All IBD samples and PC samples showed signs of Paneth cell
metaplasia as defined by DEFA6-positive cells in the crypt
base. Figure 1 displays a selection of serial sections stained by
IHC for DEFA6 and serotonin, with parallel ISH for REG1A,
REG1B, REG3A and REG4.
Table 2 LOG2 of expression values for REG family genes as mea-
sured in microarray analysis described in Granlund et al. (2011).
Background level in the full microarray gene expression analysis was
approximately 5.5 (N normal mucosa from healthy individual, UCU
un-inflamed mucosa from hepatic flexure of UC patient, CDU un-
inflamed mucosa from hepatic flexure in CD patient, UC inflamed
colonic mucosa from UC patient, CD inflamed colonic mucosa from
CD patient)
Diagnosis (sample number) REG1A REG1B REG3A REG4
N (205 F) 5.45 5.58 5.31 7.42
UCU (147 F) 12.27 12.87 14.03 10.11
CDU (212 F) 7.99 8.02 11.64 8.60
UC (122 S) 12.69 13.19 10.89 12.78
CD (212 S) 13.80 13.69 13.98 13.14
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The results from ISH of REG1A, REG1B, REG3A and
REG4 in IBD samples are given in Fig. 2. During inflam-
mation, the expression of all REGs increased. REG1A,
REG1B and REG3A expression expanded upwards from
the crypt base, whereas REG4 expression was higher to-
wards the luminal end of the crypts, often with no expres-
sion in the lower third. During inflammation, all REGs
appeared to be expressed by both absorptive colonocytes
and goblet cells. The expansion of REG1B and to some
degree of REG3A mRNA expression during inflammation,
seemed limited compared with that for REG1A, rarely
stretching much beyond the bottom third of the crypts.
REG1A mRNA, on the other hand, could in some instances
be found up to almost the luminal face, although the expres-
sion was limited to the lower half in most crypts. In un-
inflamed samples, epithelial REG1A expression seemed to
be limited to selected crypts. By closely inspecting serial
sections, one could observe a correlation between the pres-
ence of Paneth cells and epithelial REG expression; a typical
example is shown in Fig. 3. In some crypts of un-inflamed
IBD mucosa and in all inflamed samples, REG4 expression
was apparent in epithelial cells. The expression was stron-
gest towards the luminal face of the sections. REG4 posi-
tivity was also seen in scattered enteroendocrine cells in
samples with no REG4 positivity in epithelial cells. Figure 4
presents serial sections displaying these cells, demonstrating
serotonin positive enteroendocrine cells expressing REG4.
A comparison of REG1A, REG3A and REG4 gene ex-
pression (as shown by ISH) and REG protein expression (as
shown by IHC) in PC is given in Fig. 5. We found a good
correlation between the extent of gene expression and pro-
tein expression. The sections used in Fig. 5 are subsequent
sections, not serial sections as used in Fig. 1, resulting in
poorer overlap between sections. The gene expression
pattern for REG1A, REG3A and REG4 was similar to that
seen in the IBD samples (results not shown).
Discussion
The colon mucosa is a rapidly renewing cell population with
most cells undergoing a pattern of crypt-base proliferation,
migration towards the lumen during differentiation and then
apoptosis and shedding on the luminal surface within 1–
2 weeks. In IBD colonic mucosa, crypt elongation is often
observed, with an increase in both proliferation and apopto-
sis (Arai et al. 1999). In addition to the general morpholog-
ical change with leucocyte infiltration being found in IBD, a
change occurs in the cellular composition of the IBD colon-
ic mucosa with, for example, Paneth cell metaplasia being
seen in both the inflamed and un-inflamed IBD colon
(Haapamäki et al. 1997; Lala et al. 2003). Changes also take
place in the number and function of serotonin-positive
enteroendocrine cells in the inflamed mucosa (Lomax et
al. 2006). Our analysis shows that metaplastic Paneth cells
in both un-inflamed samples from IBD patients and in
inflamed colonic mucosa express REG1A, REG1B and
REG3A mRNA. The main role of Paneth cells in their
normal localisation, the mucosa of the small bowel, is to
maintain homeostasis by controlling small intestinal micro-
bial load through the secretion of antimicrobial peptides
(Bevins and Salzman 2011). The function of metaplastic
Paneth cells in the colon is unknown. However, these cells
appear in the colon during inflammatory disease and pro-
duce a number of antimicrobial peptides such as DEFA6,
DEFA5 and REG3A. Thus, the Paneth cells with their
antimicrobial peptides probably have a disease-modifying
action in colonic inflammation (Cunliffe et al. 2001; Shen et
Fig. 1 Serial sections of colonic biopsy samples for in situ
hybridisation (ISH) of REGs (a–e) with corresponding immunohisto-
chemistry (IHC) for cell-type markers DEFA6 (e–g) and serotonin (h).
Metaplastic Paneth cell (arrows in a-c, e-g). Enteroendocrine cell
(arrows in d, h) Bar 30 μm. Sections a-c and e-g from un-inflamed
ulcerative colitis. Sections d and h from pseudomembraneous colitis
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al. 2005). Interestingly, Cunliffe et al. (2001) have shown a
similar expression pattern for DEFA5 as is seen for DEFA6,
REG1B and REG3A in the present work. Of these peptides,
all but REG1B have previously been demonstrated to have
an antibacterial effect. Given the similarity in the sequences
of REG1B and REG3A and given that their expression
patterns are comparable to known antibacterial peptides
such as DEFA5/6, we consider that REG1B is a good
candidate for the screening of possible antimicrobial effects.
Good cell-for-cell overlap occurs between DEFA6 and
REG1B/REG3A expression, with REG1B/REG3A being
expressed only in the crypt base and in scattered epithelial
cells of the lower crypts. REG1A shows a similar expression
pattern in un-inflamed mucosa but its expression expands to
Fig. 2 ISH of all human REGs in colonic inflammatory bowel disease
tissue. Sections are taken from samples representing un-inflamed ul-
cerative colitis (a–d), un-inflamed Crohn’s disease (e–h), inflamed
ulcerative colitis (i–l) and inflamed Crohn’s disease (m–p). ISH was
performed with probes for REG1A, REG1B, REG3A and REG4. Sam-
ple details are given Table 1. Bar 100 μm
Fig. 3 Serial sections of a
sample of un-inflamed mucosa
from the hepatic flexure of a
patient with ulcerative colitis.
DEFA6 is detected by IHC (a)
and REG1A by ISH (b). A clear
overlap is seen between crypts
containing DEFA6-positive
Paneth cells and REG1A
positivity. Bar 200 μm
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almost all cells in the lower half of the colonic crypts during
inflammation. This result is similar to that of an earlier study
of REG1A expression by Shinozaki et al. (2001). The
REG1A expression pattern suggests that newly proliferated
epithelial cells have REG1A expression capacity but that
they lose this capability during differentiation. This could be
an effect of paracrine stimulation, whereby a signal con-
veyed by basal crypt cells weakens towards the lumen. This
paracrine stimulation could originate in Paneth cells, based
on the observation that DEFA6-positive cells are always
seen in the base of crypts in which REG1A expansion to
epithelial cells occurs. A Paneth-cell-dependent epithelial
expression of REG could explain the high expression levels
in un-inflamed samples harbouring metaplastic Paneth cells.
The reported expression levels of REG1A/REG1B/REG3A in
healthy small intestine could also be explained by such amode
of induction, as Paneth cells are present in healthy small bowel
(Parikh et al. 2012). However, we have as yet been unable to
demonstrate such a correlation unequivocally.
REG4 mRNA shows a localisation that is completely
different from that of the other REGs, with expression only
in scattered cells in normal mucosa, expanding to
colonocytes of the upper colonic crypts during inflammation
and in some un-inflamed IBD samples. The area of positive
staining after expansion to colonocytes suggests that these
gain REG4 expression late in differentiation. The scattered
cells have been identified as enteroendocrine serotonin-
producing cells. However, not all serotonin-positive cells
are REG4-positive. Almost no CgA-positive/REG4-
positive/serotonin-negative cells have been seen, suggesting
that only the serotonin-positive subgroup of enteroendocrine
cells expresses REG4 in un-inflamed mucosa. However, as
several serotoninpositive/REG4-negative cells have been
observed, the full nature of REG4 expression in
enteroendocrine cells has not been elucidated. As reported
earlier, IHC shows REG4-positive staining of the mucus
excreted from goblet cells during inflammation (Granlund
et al. 2011). This clearly indicates a secretory function for
this protein. Earlier studies have suggested both a mitogenic
and migratory effect of REG4 on colon cancer cell lines
(Rafa et al. 2010). The latter observation could correlate
with the expression pattern seen in the present study, with
an expression gradient increasing towards the lumen, possi-
bly stimulating colonocytes migration towards the luminal
face after proliferation in the crypt base. However, little
evidence supports such an effect of REG4 in non-
neoplastic disease and hence further research is needed to
identify the role of REG4 in the setting up of epithelial
inflammation.
In conclusion, the expression pattern of REG family
genes can be divided into at least two groups. REG1A,
REG1B and REG3 show an apparently Paneth-cell-
Fig. 4 Serial sections of a sample of un-inflamed mucosa from the
hepatic flexure of a patient with Crohn’s disease. IHC for serotonin (a)
and ISH for REG4 (b) and CgA (c) expression (CGA chromogranin A).
A clear overlap of expression can be seen for all three markers, with the
number of positive cells being highest for CgA and the lowest for
REG4
Fig. 5 Sequential sections
showing overlap of the extent
of REG mRNA and protein
expression in
pseudomembranous colitis.
ISH/IHC was performed for
REG1A (a/d), REG3A (b/e)
and REG4 (c/f). No suitable
protein antibody was found for
REG1B. Bar 100 μm
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dependent expansion from the colonic crypts during inflam-
mation, whereas REG4 is expressed in serotonin-producing
enteroendocrine cells and expands to epithelial cells of the
upper colonic crypts during inflammation. A similar expres-
sion pattern is also seen in non-IBD colonic inflammation,
as represented by PC. The expression pattern of REG1A and
REG1B, seen together with sequence similarities with
REG3A, suggests that these peptides are good candidates
for the screening of antimicrobial effects.
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